Home › NCT06107361

Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival

Who can join

Ages 18 and older · All sexes

Study Participants Inclusion Criteria:

≥ than 18 years old Vascular Access Score of 4 or 5

Vascular Access Score:

1. Visible with distention and easily palpable
2. Visible and easily palpable
3. Not visible and easily palpable
4. Visible and poorly palpable
5. Not visible and poorly or non-palpable

Study participants exclusion criteria:

\<18 years old Restricted mobility of elbow joint Cognitively impaired. Skin complications that limit access to the potential IV site

Clinician Participants Inclusion Criteria:

Clinician working in the emergency department at Corewell Health William Beaumont University Hospital (physician, advanced practice provider, nurse, technician) Competency in Operation STICK, which is an vascular access training program.

Clinician participants exclusion criteria:

None

About the study

This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.

What is being tested

• B. Braun 6.35cm 20 gauge ultralong intravenous catheter (device)
• BD 5.71 cm 20 gauge Accucath (device)

Sponsor: Corewell Health East · Participants: 360 · Started: Nov 7, 2023

Contact the study team

• Amit Bahl, MD · Phone: 248-898-9111
• Maureen Cooney, RN · Phone: 248-551-0099

Official record on ClinicalTrials.gov — NCT06107361

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.